Reuters logo
BRIEF-NanoVibronix reports progress on three clinical trials
December 22, 2016 / 12:40 PM / a year ago

BRIEF-NanoVibronix reports progress on three clinical trials

Dec 22 (Reuters) - NanoVibronix Inc

* PainShield study is expected to be concluded during first half of 2017

* NanoVibronix Inc - For UroShield clinical trial is underway and is expected to be concluded within five months

* NanoVibronix reports progress on three clinical trials Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below